Delta-Fly Pharma Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Public

  • Employees
  • 12

Employees

  • Stock Symbol
  • 4598

Stock Symbol

  • Share Price
  • $0.36
  • (As of Tuesday Closing)

Delta-Fly Pharma General Information

Description

Delta-Fly Pharma Inc is a Japan-based company mainly engaged in the discovery and development of gentle anti-cancer agents with module technology.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 37-5 Nishikino, Miyajima
  • Kawauchi-cho
  • Tokushima, Tokushima Prefecture 771-0116
  • Japan
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
TKS
Corporate Office
  • 37-5 Nishikino, Miyajima
  • Kawauchi-cho
  • Tokushima, Tokushima Prefecture 771-0116
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Delta-Fly Pharma Stock Performance

As of 17-Nov-2026, Delta-Fly Pharma’s stock price is $0.36. Its current market cap is $5.17M with 14.2M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.36 $0.36 $0.34 - $4.46 $5.17M 14.2M 1.43M -$0.93

Delta-Fly Pharma Financials Summary

As of 31-Mar-2026, Delta-Fly Pharma has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 31-Mar-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 12,109 12,109 32,287 34,069
Revenue 0 0 0 0
EBITDA (10,768) (10,768) (11,262) (9,865)
Net Income (10,788) (10,788) (11,286) (9,893)
Total Assets 1,543 1,543 2,902 9,740
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Delta-Fly Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Delta-Fly Pharma‘s full profile, request access.

Request a free trial

Delta-Fly Pharma Patents

Delta-Fly Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026203214-A1 Pharmaceutical preparation stable over long period of time Pending 27-Mar-2025
JP-2025187628-A Treatment for terminal pancreatic cancer Pending 14-Jun-2024
US-11684582-B2 Method for stabilizing humidity-sensitive pharmaceutical substance and stabilized preparation thereof Active 31-Mar-2021
US-20220313613-A1 Method for stabilizing humidity-sensitive pharmaceutical substance and stabilized preparation thereof Active 31-Mar-2021
EP-4091614-B1 Method for stabilizing medicinal substance sensitive to humidity (dfp-11207), and stable preparation thereof Active 31-Mar-2021 A61K31/513
To view Delta-Fly Pharma’s complete patent history, request access »

Delta-Fly Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Delta-Fly Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Delta-Fly Pharma‘s full profile, request access.

Request a free trial

Delta-Fly Pharma ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Delta-Fly Pharma’s complete esg history, request access »

Delta-Fly Pharma FAQs

  • When was Delta-Fly Pharma founded?

    Delta-Fly Pharma was founded in 2010.

  • Where is Delta-Fly Pharma headquartered?

    Delta-Fly Pharma is headquartered in Tokushima, Japan.

  • What is the size of Delta-Fly Pharma?

    Delta-Fly Pharma has 12 total employees.

  • What industry is Delta-Fly Pharma in?

    Delta-Fly Pharma’s primary industry is Drug Discovery.

  • Is Delta-Fly Pharma a private or public company?

    Delta-Fly Pharma is a Public company.

  • What is Delta-Fly Pharma’s stock symbol?

    The ticker symbol for Delta-Fly Pharma is 4598.

  • What is the current stock price of Delta-Fly Pharma?

    As of 17-Nov-2026 the stock price of Delta-Fly Pharma is $0.36.

  • What is the current market cap of Delta-Fly Pharma?

    The current market capitalization of Delta-Fly Pharma is $5.17M.

  • What is Delta-Fly Pharma’s annual earnings per share (EPS)?

    Delta-Fly Pharma’s EPS for 12 months was -$0.93.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process